United Services Automobile Association Kala Pharmaceuticals, Inc. Transaction History

United Services Automobile Association

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$3.57 - $6.58 $87,029 - $160,407	-24,378 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$4.93 - $8.8 $788 - $1,408	160 Added 0.66%	24,378 $156,000
Q4 2018 Feb 13, 2019	BUY	$4.29 - $9.94 $26,117 - $60,514	6,088 Added 33.58%	24,218 $118,000
Q3 2018 Nov 13, 2018	SELL	$9.54 - $13.87 $2,671 - $3,883	-280 Reduced 1.52%	18,130 $179,000
Q1 2018 May 14, 2018	SELL	$12.26 - $18.98 $6,350 - $9,831	-518 Reduced 2.74%	18,410 $291,000
Q4 2017 Feb 14, 2018	BUY	$13.68 - $23.17 $4,487 - $7,599	328 Added 1.76%	18,928 $350,000
Q3 2017 Nov 14, 2017	BUY	$19.86 - $26.53 $369,396 - $493,458	18,600	18,600 $425,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.81M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.